Lexicon Pharmaceuticals, Inc.
€1.868
EUR
Last updated on --.
24h volume954.75K
24h highest1.8941 EUR
24h lowest1.7567 EUR
24h Price movement+5.58%
LXRX recent prices
24 Hours
+5.58%+€0.098785
30 days
+21.60%+€0.31354
60 days
+30.91%+€0.43809
90 days
+37.00%+€0.47675
Key data
Previous close1.7695 EUR
Market cap843.26M EUR
Volume954.75K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.05154 EUR
Net income (FY)-22.41M EUR
Revenue (FY)59.69M EUR
Last report dateMay 7, 2026
About Lexicon Pharmaceuticals, Inc.
HeadquartersTHE WOODLANDS
Employees (FY)81.00
Revenue per employee (FY)736.91K EUR
Net income per employee (FY)-276.68K EUR
Listed onNasdaq
LXRX conversion tables
 |  |
|---|---|
| 0.5 LXRX | 0.93416 EUR |
| 1 LXRX | 1.868 EUR |
| 5 LXRX | 9.341 EUR |
| 10 LXRX | 18.68 EUR |
| |
|---|---|
| 0.5 EUR | 0.26762 LXRX |
| 1 EUR | 0.53524 LXRX |
| 5 EUR | 2.676 LXRX |
| 10 EUR | 5.352 LXRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LXRX is trading at €1.868, +5.58% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LXRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LXRX is currently trading at €1.868, +5.58% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LXRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LXRX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LXRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LXRX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lexicon Pharmaceuticals, Inc.'s market cap is currently 843.26M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume954.75K
24h highest1.8941 EUR
24h lowest1.7567 EUR
24h Price movement+5.58%
Start trade with LXRX Perpetual
Sign up to trade